Cargando…
Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials. In this study, we investigated the mechanisms of Qing-Re-Xiao-Zheng-Yi-Qi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807870/ https://www.ncbi.nlm.nih.gov/pubmed/36605399 http://dx.doi.org/10.3389/fphar.2022.992597 |
_version_ | 1784862807019225088 |
---|---|
author | Wu, Qiaoru Yan, Runze Yang, Hanwen Wang, Yixuan Zhang, Chao Zhang, Jiale Cui, Zhaoli Wang, Yaoxian Sun, Weiwei |
author_facet | Wu, Qiaoru Yan, Runze Yang, Hanwen Wang, Yixuan Zhang, Chao Zhang, Jiale Cui, Zhaoli Wang, Yaoxian Sun, Weiwei |
author_sort | Wu, Qiaoru |
collection | PubMed |
description | Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials. In this study, we investigated the mechanisms of Qing-Re-Xiao-Zheng-Yi-Qi Formula in the treatment of diabetic kidney disease. Methods: We used Vanquish UHPLC(TM) to analyze the chemical profiling of Qing-Re-Xiao-Zheng-Yi-Qi Formula freeze-dried powder. We constructed diabetic kidney disease rat models induced by unilateral nephrectomy and high-dose streptozocin injection. We examined blood urea nitrogen, serum creatinine, serum glucose, total cholesterol, triglyceride, serum total protein, albumin, alanine aminotransferase, aspartate aminotransferase and 24 h urinary total protein in diabetic kidney disease rats. The renal pathological changes were observed by HE, Masson, PAS stanning and transmission electron microscopy. The levels of fibrosis-related proteins and mitophagy-related proteins were detected by western blot analysis. We also conducted an immunofluorescence co-localization analysis on podocytes to further investigate the effect of Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment on mitophagy. Results: A total of 27 constituents in Qing-Re-Xiao-Zheng-Yi-Qi Formula were tentatively identified. We found PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could raise body weight and reduce renal index, reduce proteinuria, improve glycolipid metabolic disorders, ameliorate renal fibrosis, and reduce the expression of Col Ⅳ and TGF-β1 in diabetic kidney disease rats. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could also increase the expression of nephrin, activate mitophagy and protect podocytes in diabetic kidney disease rats and high glucose cultured podocytes. Conclusion: PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease, and Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could not only ameliorate pathological damage, but also promote mitophagy to protect podocytes in diabetic kidney disease. |
format | Online Article Text |
id | pubmed-9807870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98078702023-01-04 Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease Wu, Qiaoru Yan, Runze Yang, Hanwen Wang, Yixuan Zhang, Chao Zhang, Jiale Cui, Zhaoli Wang, Yaoxian Sun, Weiwei Front Pharmacol Pharmacology Introduction: Qing-Re-Xiao-Zheng-Yi-Qi Formula is an effective prescription in diabetic kidney disease treatment, we have confirmed the efficacy of Qing-Re-Xiao-Zheng therapy in diabetic kidney disease through clinical trials. In this study, we investigated the mechanisms of Qing-Re-Xiao-Zheng-Yi-Qi Formula in the treatment of diabetic kidney disease. Methods: We used Vanquish UHPLC(TM) to analyze the chemical profiling of Qing-Re-Xiao-Zheng-Yi-Qi Formula freeze-dried powder. We constructed diabetic kidney disease rat models induced by unilateral nephrectomy and high-dose streptozocin injection. We examined blood urea nitrogen, serum creatinine, serum glucose, total cholesterol, triglyceride, serum total protein, albumin, alanine aminotransferase, aspartate aminotransferase and 24 h urinary total protein in diabetic kidney disease rats. The renal pathological changes were observed by HE, Masson, PAS stanning and transmission electron microscopy. The levels of fibrosis-related proteins and mitophagy-related proteins were detected by western blot analysis. We also conducted an immunofluorescence co-localization analysis on podocytes to further investigate the effect of Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment on mitophagy. Results: A total of 27 constituents in Qing-Re-Xiao-Zheng-Yi-Qi Formula were tentatively identified. We found PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could raise body weight and reduce renal index, reduce proteinuria, improve glycolipid metabolic disorders, ameliorate renal fibrosis, and reduce the expression of Col Ⅳ and TGF-β1 in diabetic kidney disease rats. Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could also increase the expression of nephrin, activate mitophagy and protect podocytes in diabetic kidney disease rats and high glucose cultured podocytes. Conclusion: PINK1/Parkin-mediated mitophagy was inhibited in diabetic kidney disease, and Qing-Re-Xiao-Zheng-Yi-Qi Formula treatment could not only ameliorate pathological damage, but also promote mitophagy to protect podocytes in diabetic kidney disease. Frontiers Media S.A. 2022-12-20 /pmc/articles/PMC9807870/ /pubmed/36605399 http://dx.doi.org/10.3389/fphar.2022.992597 Text en Copyright © 2022 Wu, Yan, Yang, Wang, Zhang, Zhang, Cui, Wang and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Wu, Qiaoru Yan, Runze Yang, Hanwen Wang, Yixuan Zhang, Chao Zhang, Jiale Cui, Zhaoli Wang, Yaoxian Sun, Weiwei Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease |
title | Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease |
title_full | Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease |
title_fullStr | Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease |
title_full_unstemmed | Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease |
title_short | Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease |
title_sort | qing-re-xiao-zheng-yi-qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807870/ https://www.ncbi.nlm.nih.gov/pubmed/36605399 http://dx.doi.org/10.3389/fphar.2022.992597 |
work_keys_str_mv | AT wuqiaoru qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT yanrunze qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT yanghanwen qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT wangyixuan qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT zhangchao qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT zhangjiale qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT cuizhaoli qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT wangyaoxian qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease AT sunweiwei qingrexiaozhengyiqiformularelieveskidneydamageandactivatesmitophagyindiabetickidneydisease |